What did we REALLY learn from the NordICC colonoscopy study?

NCI study: Prevention and screening saved more lives than treatment in five common cancer types over the past half-century

Over the last 45 years, prevention and screening interventions have made a greater contribution to averting cancer deaths than have improvements in treatment, according to a modeling study led by researchers at NCI.

January 31, 2025

Vol.51 No.04

By Yiqing Wang and Jacquelyn Cobb

Clinical Roundup

Adjuvant Celebrex may reduce risk of colon cancer recurrence in patients with evidence of ctDNA

A data analysis from a randomized phase III clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham Cancer Center found that patients with evidence of residual cancer in their blood after surgery to remove the cancer may benefit from adding Celebrex (celecoxib) to post-surgery treatment.

January 31, 2025

Vol.51 No.04

ACS report: Cancer mortality continues to drop despite rising incidence in women

Despite steady progress in reducing overall cancer mortality rates, cancer incidence in women is rising, according to the American Cancer Society’s “Cancer Statistics, 2025” report. Incidence rates in women 50-64 years of age have surpassed those in men, and rates in women under 50 are now 82% higher than their male counterparts, up from 51% higher in 2002. In 2021, for the first time, lung cancer incidence was higher in women under 65 than in men.

January 17, 2025

Vol.51 No.02

By Yiqing Wang

In Brief

UNM’s Julie In awarded $1.9M to study uranium exposure on intestinal lining

Julie In received a $1.9 million grant from the National Institute of Environmental Health Sciences to study the impact of uranium on the cells that line the intestines.

December 13, 2024

Vol.50 No.46

In Brief

Rural Appalachian lung cancer screening initiative expands screening access

UVA Cancer Center, Appalachian Community Cancer Alliance, and Buchanan General Hospital have teamed up to make getting screened for lung cancer easier for residents of rural Virginia and West Virginia.

December 06, 2024

Vol.50 No.45

Clinical Roundup

Home testing kits, coordinated outreach improve CRC screening rates

Colorectal cancer screening is an effective tool for catching the disease early when it’s most treatable, yet it is underutilized in patient populations who receive primary care at federally qualified health centers.

December 06, 2024

Vol.50 No.45

What did we REALLY learn from the NordICC colonoscopy study?

YOU MAY BE INTERESTED IN

NCI study: Prevention and screening saved more lives than treatment in five common cancer types over the past half-century

Adjuvant Celebrex may reduce risk of colon cancer recurrence in patients with evidence of ctDNA

ACS report: Cancer mortality continues to drop despite rising incidence in women

UNM’s Julie In awarded $1.9M to study uranium exposure on intestinal lining

Rural Appalachian lung cancer screening initiative expands screening access

Home testing kits, coordinated outreach improve CRC screening rates

Renew today!

Subscriber content

Never miss an issue!

Login